Cornell researchers have developed a robotic feeding system that uses computer vision, machine learning and multimodal sensing to safely feed people with severe mobility limitations, including those with spinal cord injuries, cerebral palsy and multiple sclerosis.
A new Weill Cornell Medicine study solves a 50-year mystery and suggests that faulty mRNA modification may underlie some autoimmune and inflammatory disorders.
A cellular process known as autophagy that helps rid cells of debris may be impaired in pregnant women who go on to develop postpartum depression, according to new research from Weill Cornell Medicine.
Multiple types of beta cells produce insulin in the pancreas, helping to balance blood sugar levels. Losing a particularly productive type of beta cell may contribute to the development of diabetes, according to a new study by Weill Cornell Medicine investigators.
Featuring a unique instrumentation of trumpet, trombone, bass clarinet, and baritone voice, loadbang headlines a week of great musical performances April 11-17.
Big Red Ventures (BRV), Cornell University’s early-stage venture capital fund run by MBAs and other graduate students, presented its portfolio and announced a new investment during the Annual Meeting on April 18 at Cornell Tech.
One in six assisted living facility residents is subject to verbal, physical or other aggression by a fellow resident in a typical month, according to the first large-scale study of the phenomenon.
Mario Herrero, Timothy Ryan, M.S. ’86, Ph.D. ’89, Steven Strogatz and Peter Wolczanski are Cornell’s 2024 electees to the National Academy of Sciences, the academy announced April 30 at the close of its 161st annual meeting.
The key to understanding how the most aggressive lymphomas arise and resist current therapies may lie in mutations that disrupt a critical natural selection process among antibody-producing B cells, according to a multi-institutional preclinical study led by Weill Cornell Medicine investigators.